Aug. 17 at 10:35 PM
$PPBT
Yael Margolin: The
$1.4B Signal
Yael Margolin didn’t walk in from nowhere.
She walked in fresh off a
$1.4B Eli Lilly buyout of Point Biopharma.
What does that signal?
👉 She knows what a real acquisition looks like
👉 She knows how to prepare a company for one
👉 She knows the timing, silence, and structure of pre‑deal behavior
👉 She doesn’t join companies with “no future”
Executives with billion‑dollar exits don’t take seats on sinking ships.
They take seats on the next one.
